Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection

Recurrent Clostridioides difficile infections (rCDI) have a substantial impact on healthcare systems, with limited and often expensive therapeutic options. Nonalcoholic fatty liver disease (NAFLD) affects about 25% of the adult population and is associated with metabolic syndrome, changes in gut mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Šamadan, Lara, Jeličić, Mia, Vince, Adriana, Papić, Neven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300633/
https://www.ncbi.nlm.nih.gov/pubmed/34198964
http://dx.doi.org/10.3390/antibiotics10070780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300633/
https://www.ncbi.nlm.nih.gov/pubmed/34198964
http://dx.doi.org/10.3390/antibiotics10070780

Ejemplares similares